Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate
- PMID: 18716168
- DOI: 10.1093/jn/138.9.1671
Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate
Abstract
Flavanols from chocolate appear to increase nitric oxide bioavailability, protect vascular endothelium, and decrease cardiovascular disease (CVD) risk factors. We sought to test the effect of flavanol-rich dark chocolate (FRDC) on endothelial function, insulin sensitivity, beta-cell function, and blood pressure (BP) in hypertensive patients with impaired glucose tolerance (IGT). After a run-in phase, 19 hypertensives with IGT (11 males, 8 females; 44.8 +/- 8.0 y) were randomized to receive isocalorically either FRDC or flavanol-free white chocolate (FFWC) at 100 g/d for 15 d. After a wash-out period, patients were switched to the other treatment. Clinical and 24-h ambulatory BP was determined by sphygmometry and oscillometry, respectively, flow-mediated dilation (FMD), oral glucose tolerance test, serum cholesterol and C-reactive protein, and plasma homocysteine were evaluated after each treatment phase. FRDC but not FFWC ingestion decreased insulin resistance (homeostasis model assessment of insulin resistance; P < 0.0001) and increased insulin sensitivity (quantitative insulin sensitivity check index, insulin sensitivity index (ISI), ISI(0); P < 0.05) and beta-cell function (corrected insulin response CIR(120); P = 0.035). Systolic (S) and diastolic (D) BP decreased (P < 0.0001) after FRDC (SBP, -3.82 +/- 2.40 mm Hg; DBP, -3.92 +/- 1.98 mm Hg; 24-h SBP, -4.52 +/- 3.94 mm Hg; 24-h DBP, -4.17 +/- 3.29 mm Hg) but not after FFWC. Further, FRDC increased FMD (P < 0.0001) and decreased total cholesterol (-6.5%; P < 0.0001), and LDL cholesterol (-7.5%; P < 0.0001). Changes in insulin sensitivity (Delta ISI - Delta FMD: r = 0.510, P = 0.001; Delta QUICKI - Delta FMD: r = 0.502, P = 0.001) and beta-cell function (Delta CIR(120) - Delta FMD: r = 0.400, P = 0.012) were directly correlated with increases in FMD and inversely correlated with decreases in BP (Delta ISI - Delta 24-h SBP: r = -0.368, P = 0.022; Delta ISI - Delta 24-h DBP r = -0.384, P = 0.017). Thus, FRDC ameliorated insulin sensitivity and beta-cell function, decreased BP, and increased FMD in IGT hypertensive patients. These findings suggest flavanol-rich, low-energy cocoa food products may have a positive impact on CVD risk factors.
Similar articles
-
Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives.Hypertension. 2005 Aug;46(2):398-405. doi: 10.1161/01.HYP.0000174990.46027.70. Epub 2005 Jul 18. Hypertension. 2005. PMID: 16027246 Clinical Trial.
-
Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons.Am J Clin Nutr. 2005 Mar;81(3):611-4. doi: 10.1093/ajcn/81.3.611. Am J Clin Nutr. 2005. PMID: 15755830 Clinical Trial.
-
Protective effects of flavanol-rich dark chocolate on endothelial function and wave reflection during acute hyperglycemia.Hypertension. 2012 Sep;60(3):827-32. doi: 10.1161/HYPERTENSIONAHA.112.193995. Epub 2012 Jul 30. Hypertension. 2012. PMID: 22851734 Clinical Trial.
-
Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials.Am J Clin Nutr. 2012 Mar;95(3):740-51. doi: 10.3945/ajcn.111.023457. Epub 2012 Feb 1. Am J Clin Nutr. 2012. PMID: 22301923 Review.
-
Blood pressure and cardiovascular risk: what about cocoa and chocolate?Arch Biochem Biophys. 2010 Sep 1;501(1):112-5. doi: 10.1016/j.abb.2010.05.020. Epub 2010 Jun 1. Arch Biochem Biophys. 2010. PMID: 20494650 Review.
Cited by 94 articles
-
Effects of Cocoa-Rich Chocolate on Blood Pressure, Cardiovascular Risk Factors, and Arterial Stiffness in Postmenopausal Women: A Randomized Clinical Trial.Nutrients. 2020 Jun 12;12(6):1758. doi: 10.3390/nu12061758. Nutrients. 2020. PMID: 32545478 Free PMC article.
-
Antidiabetic Effects of Flavan-3-ols and Their Microbial Metabolites.Nutrients. 2020 May 29;12(6):1592. doi: 10.3390/nu12061592. Nutrients. 2020. PMID: 32485837 Free PMC article. Review.
-
Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.Eur J Pharmacol. 2020 Jul 15;879:173089. doi: 10.1016/j.ejphar.2020.173089. Epub 2020 Apr 19. Eur J Pharmacol. 2020. PMID: 32320701
-
Racial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction.Am J Physiol Heart Circ Physiol. 2019 Oct 1;317(4):H777-H789. doi: 10.1152/ajpheart.00126.2019. Epub 2019 Aug 9. Am J Physiol Heart Circ Physiol. 2019. PMID: 31397168 Review.
-
The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study.Front Endocrinol (Lausanne). 2019 May 9;10:296. doi: 10.3389/fendo.2019.00296. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31143160 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical